ALK-rearranged carcinomas are less frequent than those with RET or NTRK rearrangements, and typically involve fusion with partner genes, such as STRN (encoding striatin) or EML4 (also involved in lung adenocarcinoma) (75, 76, 80, 83). The gene discussed is ALK; the disease is carcinoma.